Jacob Gottlieb and Stuart Weisbrod have recently decided to team up again and work together for the first time in more than 20 years. They had previously worked with each other at Merlin BioMed Group and are now looking ahead to the future of their business relationship. Merlin was co-founded by Weisbrod and opened up as an investment management company that works with health care companies. Weisbrod had already worked with many different successful investment companies and had plenty of experience bringing the right people together to work as a team.
Jacob Gottlieb was a part of his team back in 2000 and served as a portfolio manager for Merlin. He helped the company to earn plenty of money while there and also connected Merlin with the right clients. Merlin did very well during its run but ended up closing down in 2007. Weisbrod started up Iguana Healthcare Partners afterwards, which is an investment firm that focuses on the health care sector, and Jacob Gottlieb went on to startup Visium Asset Management. He took an initial $300 million and turned that into $2.5 billion rather quickly. He managed to get through the financial crash of 2008 and grew the fund into $8 billion.
In 2016, Jacob Gottlieb decided to move onto bigger and better things after some of the executives of his company were accused of insider trading. Gottlieb was never charged with anything, at all, and kept the company open long enough to pay investors back their money. It should be exciting to see what Gottlieb and Weisbrod do together, and the health care industry should benefit from their collaboration. Gottlieb is now working with Altium Capital, and he has decided to invest in Oramed Pharmaceuticals Inc., which is a company that is transforming the health care industry. Oramed is still seeking the approval of the FDA with its products but is making progress with its insulin capsule product. This product and other products that the company is working on are capable of making big changes in the lives of people who have suffered with diabetes for far too long.